Real-time enrollment status for this retinoblastoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:43 AM UTC
| NCT Number | NCT03932786 |
| Recruiting Status | Recruiting |
| Condition | Retinoblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 900 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | September 19, 2025 (Sep 19, 2025) |
As of July 13, 2026: Clinical trial NCT03932786 is currently recruiting participants. This clinical trial study for retinoblastoma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03932786 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03932786 was last updated Sep 19, 2025 (September 19, 2025). HelloStudys verifies this status automatically.